These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36578466)

  • 1. Oxidized LDL is stable in human serum under extended thawed-state conditions ranging from -20 °C to room temperature.
    Jehanathan N; Kapuruge EP; Rogers SP; Williams S; Chung Y; Borges CR
    J Mass Spectrom Adv Clin Lab; 2023 Jan; 27():18-23. PubMed ID: 36578466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking the Stability of Clinically Relevant Blood Plasma Proteins with Delta-S-Cys-Albumin-A Dilute-and-Shoot LC/MS-Based Marker of Specimen Exposure to Thawed Conditions.
    Kapuruge EP; Jehanathan N; Rogers SP; Williams S; Chung Y; Borges CR
    Mol Cell Proteomics; 2022 Nov; 21(11):100420. PubMed ID: 36182099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
    Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
    J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemically Tracked Variability of Blood Plasma Thawed-State Exposure Times in a Multisite Collection Study.
    Hu Y; Mulot C; Bourreau C; Martin D; Laurent-Puig P; Radoï L; Guénel P; Borges CR
    Biopreserv Biobank; 2020 Oct; 18(5):376-388. PubMed ID: 32608993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta-S-Cys-Albumin: A Lab Test that Quantifies Cumulative Exposure of Archived Human Blood Plasma and Serum Samples to Thawed Conditions.
    Jeffs JW; Jehanathan N; Thibert SMF; Ferdosi S; Pham L; Wilson ZT; Breburda C; Borges CR
    Mol Cell Proteomics; 2019 Oct; 18(10):2121-2137. PubMed ID: 31324658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High oxidative stress in patients with stable coronary heart disease.
    Weinbrenner T; Cladellas M; Isabel Covas M; Fitó M; Tomás M; Sentí M; Bruguera J; Marrugat J
    Atherosclerosis; 2003 May; 168(1):99-106. PubMed ID: 12732392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
    Tsimikas S; Bergmark C; Beyer RW; Patel R; Pattison J; Miller E; Juliano J; Witztum JL
    J Am Coll Cardiol; 2003 Feb; 41(3):360-70. PubMed ID: 12575961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.
    Faviou E; Vourli G; Nounopoulos C; Zachari A; Dionyssiou-Asteriou A
    Free Radic Res; 2005 Apr; 39(4):419-29. PubMed ID: 16028367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of oxidized platelet lipidome: implications for coronary artery disease.
    Chatterjee M; Rath D; Schlotterbeck J; Rheinlaender J; Walker-Allgaier B; Alnaggar N; Zdanyte M; Müller I; Borst O; Geisler T; Schäffer TE; Lämmerhofer M; Gawaz M
    Eur Heart J; 2017 Jul; 38(25):1993-2005. PubMed ID: 28431006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
    Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
    Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to oxidized low-density lipoprotein in patients following coronary artery revascularization.
    Miller ER; Erlinger TP; Blumenthal RS; Margolis S; Allen JK
    Coron Artery Dis; 2003 Apr; 14(2):163-9. PubMed ID: 12655280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oxidized LDL and C-reactive protein as markers for detection of accelerated atherosclerosis in type 2 diabetes].
    Caparević Z; Kostić N; Ilić S; Stojanović D; Ivanović AM
    Med Pregl; 2006; 59(3-4):160-4. PubMed ID: 17066589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antibodies to oxidized low-density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease.
    Soltesz P; Veres K; Laczik R; Der H; Csipo I; Timar O; Szomjak E; Szegedi G; Szodoray P
    Thromb Haemost; 2007 Aug; 98(2):413-9. PubMed ID: 17721625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells.
    Bird DA; Gillotte KL; Hörkkö S; Friedman P; Dennis EA; Witztum JL; Steinberg D
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6347-52. PubMed ID: 10339590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma protein lipofuscin-like fluorophores in men with coronary artery disease treated with statins.
    Sutherland WH; Williams MJ; de Jong SA
    Arch Med Res; 2007 Oct; 38(7):757-63. PubMed ID: 17845895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
    Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of oxidized low-density lipoproteins in gingival crevicular fluid from dental patients.
    Sakiyama Y; Kato R; Inoue S; Suzuki K; Itabe H; Yamamoto M
    J Periodontal Res; 2010 Apr; 45(2):216-22. PubMed ID: 19778326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
    Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
    Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of oxidized low density lipoprotein are associated with stable angina pectoris and modalities of acute coronary syndrome.
    Imazu M; Ono K; Tadehara F; Kajiwara K; Yamamoto H; Sumii K; Tasaki N; Oiwa J; Shimohara Y; Gomyo Y; Itabe H
    Int Heart J; 2008 Sep; 49(5):515-24. PubMed ID: 18971563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease.
    Granér M; Kahri J; Nakano T; Sarna SJ; Nieminen MS; Syvänne M; Taskinen MR
    Eur J Clin Invest; 2006 Nov; 36(11):764-70. PubMed ID: 17032343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.